Amgen (Germany) Insiders
| AMG Stock | 255.90 7.15 2.87% |
Amgen employs about 25.2 K people. The company is managed by 10 executives with a total tenure of roughly 58800 years, averaging almost 5880.0 years of service per executive, having 2520.0 employees per reported executive. Breaking down Amgen's management performance can provide insight into the firm performance.
| Robert Bradway Chairman CEO Chairman |
Amgen |
Amgen Management Team Effectiveness
The company has return on total asset (ROA) of 0.0997 % which means that it generated a profit of $0.0997 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 1.2647 %, meaning that it generated $1.2647 on every $100 dollars invested by stockholders. Amgen's management efficiency ratios could be used to measure how well Amgen manages its routine affairs as well as how well it operates its assets and liabilities.Amgen Workforce Comparison
Amgen Inc is rated fifth in number of employees category among its peers. The total workforce of Drug Manufacturers-General industry is presently estimated at about 414,621. Amgen holds roughly 25,200 in number of employees claiming about 6% of equities under Drug Manufacturers-General industry.
The company has Profit Margin (PM) of 0.25 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.38 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.38. Amgen Inc Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Amgen Inc Price Series Summation is a cross summation of Amgen price series and its benchmark/peer.
Amgen Notable Stakeholders
An Amgen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Amgen often face trade-offs trying to please all of them. Amgen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Amgen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Robert Bradway | CEO Chairman | Profile | |
| Peter Griffith | Ex CFO | Profile | |
| Linda Louie | VP Officer | Profile | |
| Jonathan Graham | Gen VP | Profile | |
| Mike Zahigian | VP Officer | Profile | |
| Arvind Sood | VP Relations | Profile | |
| Murdo Gordon | Ex Operations | Profile | |
| Esteban Santos | Ex Operations | Profile | |
| Nancy Grygiel | Sr Officer | Profile | |
| David MD | Ex RD | Profile |
About Amgen Management Performance
The success or failure of an entity such as Amgen Inc often depends on how effective the management is. Amgen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Amgen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Amgen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the imprecision that can be found in Amgen's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Amgen Inc. Check Amgen's Beneish M Score to see the likelihood of Amgen's management manipulating its earnings.
Amgen Workforce Analysis
Traditionally, organizations such as Amgen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Amgen within its industry.Amgen Manpower Efficiency
Return on Amgen Manpower
| Revenue Per Employee | 1M | |
| Revenue Per Executive | 2.6B | |
| Net Income Per Employee | 260K | |
| Net Income Per Executive | 655.2M |
Additional Tools for Amgen Stock Analysis
When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.